Atrandi Biosciences

About Atrandi Biosciences

Atrandi Biosciences is focused on enabling the century of biology through next-generation single-cell technology. Their innovation centers on Semi-Permeable Capsules (SPCs), which redefine single-cell analysis by isolating thousands of cells for high-throughput single-cell omics and multiomics, maintaining single-cell resolution during bulk reactions.

Products & Services

Flux:A platform for single-cell analysis.

Single-Cell Microbial WGS Kit:A kit for single-cell microbial whole genome sequencing.

SPC Innovator Kit:A kit for innovating with Semi-Permeable Capsules.

Consumables:Additional materials for single-cell analysis applications.

Specialties

Single-Cell Analysis Semi-Permeable Capsules (SPCs) High-Throughput Single-Cell Omics Single-Cell Multiomics Droplet Microfluidics Single-Cell Eukaryotic DNA Sequencing Single-Cell Microbial Genomics High-Throughput Screening

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 25000000 MR: - FA: 25 million FAN: 25000000	D: 2025-02-19 FD: 2025-02-19	5 investors
2	RT: Funding Round T: - FT: Funding Round	A: 4800000 MR: - FA: $4.8 million FAN: 4800000	D: 2023-03-28 FD: 2023-03-28	3 investors

Series A Latest

2025-02-19

$25.0M

5 investors (Pro only)

Funding Round 2023-03-28

$4.8M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

Juozas

Chief Executive Officer

LinkedIn (Pro only)

K

Karolis

Chief Technology Officer

LinkedIn (Pro only)

R

Rapolas Žilionis

Chief Scientific Officer

L

Linas

Scientific Advisor

D

Dalius K.

Director of Engineering

D

Dalius J.

Chief Financial Officer

View 11 more team members with Pro

Unlock Full Team Directory

Recent News